{
  "ptid_time": "012_S_0720_2006-08-09",
  "img_path": "/data/qiuhui/data/adni/images/012_S_0720/2006-08-09/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 50,845 mm³, 81.2% above the reference mean. With a Z-score of 1.86 (96.8th percentile), this represents moderate enlargement; hippocampal volume measures 4,023 mm³, 43.5% below the reference mean. With a Z-score of -3.99 (0.0th percentile), this represents profound atrophy; whole brain volume measures 865,121 mm³, 11.2% below the reference mean. With a Z-score of -1.41 (7.9th percentile), this represents mild atrophy; entorhinal cortex volume measures 1,949 mm³, 46.9% below the reference mean. With a Z-score of -2.88 (0.2th percentile), this represents significant atrophy; fusiform gyrus volume measures 12,056 mm³, 29.1% below the reference mean. With a Z-score of -2.65 (0.4th percentile), this represents significant atrophy; middle temporal gyrus volume measures 11,852 mm³, 38.2% below the reference mean. With a Z-score of -3.31 (0.0th percentile), this represents profound atrophy. ",
  "text_data": "Age is 77.4 years. Gender is Female. Education: 14 years. Handedness: Right. Race: White. Medical history: Head, Eyes, Ears, Nose and Throat; Cardiovascular; Respiratory; Musculoskeletal; Gastrointestinal; Renal-Genitourinary; Allergies or Drug Sensitivities; Smoking. MMSE: 23.0. Logical Memory: 0.0. APOEε4 alleles: 0.0. Biomarker levels: Amyloid beta: 738.90 pg/mL (normal ); Total tau: 216.30 pg/mL (normal ); Phosphorylated tau: 18.57 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The imaging data show profound hippocampal atrophy, significant entorhinal cortex and fusiform gyrus atrophy, and moderate ventricular enlargement—all consistent with Alzheimer's neurodegeneration. However, normal CSF biomarkers (Aβ, T-tau, P-tau) and an MMSE of 23 (borderline impaired) complicate the picture, suggesting possible non-AD pathology or early-stage disease.  \n\n**Diagnosis:** **MCI** (given cognitive decline with MMSE 23 and structural atrophy, but normal biomarkers and no clear dementia-level functional impairment).  \n\n**Confidence:** **Medium** (biomarker discordance with imaging raises uncertainty about etiology).",
  "timestamp": "2025-07-25T23:06:14.203991"
}